acetyl farnesylcysteine은 임신 중 안전한가요?
No harmonised CLP classification, no SCCS or CIR safety assessment found for acetyl farnesylcysteine; peer‑reviewed literature shows topical/local anti‑inflammatory activity in skin models (mouse topical studies and human dermal cell studies) but no reproductive or developmental toxicity data were identified, so hazard and mechanism scores default to 0. Topical use has measurable but likely low systemic absorption in the published pharmacology/skin studies, so exposure is scored as 1. (Sources: PubMed topical/in vitro studies; absence of harmonised CLP/SCCS/CIR entries in searches).
Related ingredients
Frequently asked questions
- acetyl farnesylcysteine은 임신 중 안전한가요?
- No harmonised CLP classification, no SCCS or CIR safety assessment found for acetyl farnesylcysteine; peer‑reviewed literature shows topical/local anti‑inflammatory activity in skin models (mouse topical studies and human dermal cell studies) but no reproductive or developmental toxicity data were identified, so hazard and mechanism scores default to 0. Topical use has measurable but likely low systemic absorption in the published pharmacology/skin studies, so exposure is scored as 1. (Sources: PubMed topical/in vitro studies; absence of harmonised CLP/SCCS/CIR entries in searches).
- acetyl farnesylcysteine은 모유 수유 중 안전한가요?
- No evidence of reproductive or lactation‑related toxicity in the scientific literature or regulatory assessments. Dermal application to the breast could lead to low but measurable maternal systemic exposure (as for pregnancy), so exposure given as 1; no data show transfer into breastmilk or effects on nursing infants.
- acetyl farnesylcysteine은 아기 피부에 안전한가요?
- No infant‑specific toxicology found. Because topical AFC shows measurable activity/absorption in skin studies, baby exposure is increased by +1 to account for immature barrier and higher surface‑area‑to‑weight (adult e=1 → infant e=2). No data indicate infant‑specific hazard or mechanisms, so h and m remain 0.
- VeriMom은 acetyl farnesylcysteine을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 acetyl farnesylcysteine을 93/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 acetyl farnesylcysteine 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.